SCHEMBL1881318

SCHEMBL1881318

O=c1[nH]c2c(c(=O)[nH]1)NCN2CCCC1CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3118429 0.76 TYMP (0.36) —
SCHEMBL3236496 0.69 — —
SCHEMBL11477500 0.68 HPRT1 (0.31) —
SCHEMBL7559507 0.66 TYMP (0.37) —
SCHEMBL10181081 0.60 ALDH1A1 (0.43) —
SCHEMBL2140363 0.56 SIGMAR1 (0.31) —
SCHEMBL2140278 0.55 SIGMAR1 (0.35) —
SCHEMBL13964733 0.54 MAOA (0.39) —
SCHEMBL16058833 0.53 KDM4E (0.40) —
SCHEMBL19590938 0.51 TYMP (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499142-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF Advinus Therapeutics Limited (IN) 2012-09-19 — — EP disclosed
WO-2011055391-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-05-12 — — WO disclosed
Send feedback